Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study supplemental material

This is the supplemental material for the manuscript titled, "Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study" by Gebauer K. et al., 2024.

本材料为 Gebauer K. 等人于 2024 年撰写的题为《曲尼司珠单抗治疗头皮中度至重度斑块状银屑病的有效性和安全性：一项多中心、随机、双盲、安慰剂对照的 3b 期研究》的手稿的补充材料。